Stock 688321 SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shenzhen Chipscreen Biosciences Co., Ltd.

Equities

688321

CNE100003LW0

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
21.91 CNY +0.55% Intraday chart for Shenzhen Chipscreen Biosciences Co., Ltd. +6.00% -0.18%
Apr. 28 Shenzhen Chipscreen Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 22 Chipscreen Biosciences Offers Sell-Back Option for Microchip Convertible Bond Holders MT

Business Summary

Shenzhen Chipscreen Biosciences Co Ltd is a China-based company mainly engaged in the research and development of original innovative drugs. The Company focuses on the research and development of original innovative drugs in five therapeutic areas, including malignant tumors, metabolic diseases, autoimmune diseases, central nervous system diseases and anti-virus. The Company's main products include Chidamide, Siglitazone, Cioroni and CS12192. The Company mainly conducts its businesses in the domestic market.

Number of employees: 1,057

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chidamide
89.1 %
467 88.1 % 467 89.1 % -0.04%
Siglita Sodium
8.1 %
16 3.0 % 42 8.1 % +167.04%
Technology Licensing
1.3 %
44 8.3 % 7 1.3 % -84.89%
Other Business
1.2 %
4 0.7 % 6 1.2 % +75.02%
Other
0.4 %
- - 2 0.4 % -

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.7 %
482 91.6 % 511 98.7 % +5.92%
Taiwan
0.7 %
4 0.8 % 3 0.7 % -22.06%
United States
0.7 %
40 7.6 % 3 0.7 % -91.49%

Managers

Managers TitleAgeSince
Zhi Qiang Ning FOU
 Founder 64 01-03-20
Xian Ping Lu CEO
 Chief Executive Officer 61 01-03-20
Jian Xun Li DFI
 Director of Finance/CFO 53 01-05-31
De Si Pan CTO
 Chief Tech/Sci/R&D Officer 54 02-04-30
Shu Mei Zhao ADM
 Chief Administrative Officer 61 01-07-31
Liang Ji She PRN
 Corporate Officer/Principal 59 13-11-30
Zhi Bin Li PRN
 Corporate Officer/Principal 60 01-08-31

Members of the board

Members of the board TitleAgeSince
Li Xin Tian BRD
 Director/Board Member 58 18-03-23
Xian Ping Lu CEO
 Chief Executive Officer 61 01-03-20
Jian Xun Li DFI
 Director of Finance/CFO 53 01-05-31
Rui Lin Song BRD
 Director/Board Member 61 18-06-25
Xun Zhu BRD
 Director/Board Member 66 18-03-23
De Si Pan CTO
 Chief Tech/Sci/R&D Officer 54 02-04-30
Jie He CHM
 Chairman 39 -
Xiang Yan Li BRD
 Director/Board Member 45 18-03-23
Zheng Sheng Xie BRD
 Director/Board Member 58 21-03-17
Xia Jin BRD
 Director/Board Member 47 21-03-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 411,286,794 252,062,800 ( 61.29 %) 3,750,000 ( 0.9118 %) 61.29 %

Shareholders

NameEquities%Valuation
Tsinghua University Education Foundation
8.438 %
34,705,162 8.438 % 91 M ¥
Shenzhen Haiyuemen Biotechnology Development Co. Ltd.
5.577 %
22,936,008 5.577 % 60 M ¥
Xian Ping Lu
5.407 %
22,239,625 5.407 % 58 M ¥
Shenzhen Haide Ruibo Investment Co. Ltd.
4.818 %
19,817,445 4.818 % 52 M ¥
Jian Xun Li
3.694 %
15,192,290 3.694 % 40 M ¥
Vertex Venture Holdings Ltd
3.203 %
13,174,718 3.203 % 34 M ¥
Shenzhen Haide Ruida Enterprise Management Partnership LP
2.858 %
11,753,849 2.858 % 31 M ¥
Shenzhen Haide Ruiyuan Enterprise Management Partnership LP
2.858 %
11,753,849 2.858 % 31 M ¥
Shenzhen Haide Xincheng Investment Enterprise LP
2.290 %
9,416,540 2.290 % 25 M ¥
Sichuan State-Owned Assets Supervision & Admin. Commission
1.997 %
8,214,410 1.997 % 21 M ¥

Company contact information

Shenzhen Chipscreen Biosciences Co., Ltd.

Rm 601-606, Building 2 Shenzhen Bio Incubation Base

518057, Shenzhen

+

http://www.chipscreen.com
address Shenzhen Chipscreen Biosciences Co., Ltd.(688321)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Sales per region

Ratings for Shenzhen Chipscreen Biosciences Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
21.91 CNY
Average target price
26.33 CNY
Spread / Average Target
+20.17%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. Stock Shenzhen Chipscreen Biosciences Co., Ltd.
-0.18% 1.23B
MERCK KGAA Stock Merck KGaA
+3.37% 69.85B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+11.77% 8.98B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-12.75% 4.89B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+42.38% 4.44B
YUHAN CORPORATION Stock Yuhan Corporation
+5.23% 3.95B
INDIVIOR PLC Stock Indivior PLC
+21.69% 2.49B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-19.05% 2.4B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-28.72% 2.28B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+11.13% 1.96B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 688321 Stock
  4. Company Shenzhen Chipscreen Biosciences Co., Ltd.